Home > National Drug Code (NDC) > Nadolol and Bendroflumethiazide

Nadolol and Bendroflumethiazide - 0115-5311-01 - (NADOLOL and BENDROFLUMETHIAZIDE)

Alphabetical Index


Drug Information of Nadolol and Bendroflumethiazide

Product NDC: 0115-5311
Proprietary Name: Nadolol and Bendroflumethiazide
Non Proprietary Name: NADOLOL and BENDROFLUMETHIAZIDE
Active Ingredient(s): 5; 40    mg/1; mg/1 & nbsp;   NADOLOL and BENDROFLUMETHIAZIDE
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Nadolol and Bendroflumethiazide

Product NDC: 0115-5311
Labeler Name: Global Pharmaceuticals, Division of Impax Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA077833
Marketing Category: ANDA
Start Marketing Date: 20070401

Package Information of Nadolol and Bendroflumethiazide

Package NDC: 0115-5311-01
Package Description: 100 TABLET in 1 BOTTLE (0115-5311-01)

NDC Information of Nadolol and Bendroflumethiazide

NDC Code 0115-5311-01
Proprietary Name Nadolol and Bendroflumethiazide
Package Description 100 TABLET in 1 BOTTLE (0115-5311-01)
Product NDC 0115-5311
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name NADOLOL and BENDROFLUMETHIAZIDE
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20070401
Marketing Category Name ANDA
Labeler Name Global Pharmaceuticals, Division of Impax Laboratories, Inc.
Substance Name BENDROFLUMETHIAZIDE; NADOLOL
Strength Number 5; 40
Strength Unit mg/1; mg/1
Pharmaceutical Classes Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of Nadolol and Bendroflumethiazide


General Information